Tag Archives: Diseases

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »

Fingernail Sensor and Artificial Intelligence for Monitoring Parkinson’s, Other Diseases

December 21st, 2018 Editors Diagnostics, Neurology, Rehab Grip strength, as well as walking speed and gait length, can be indicators of a person’s physical and mental health. A variety of conditions and treatments can be monitored from the grip strength, but such measurements are typically only performed infrequently at the doctor’s office. IBM Research has… Read More »